|
注册号: Registration number: |
ChiCTR2300068527 |
|
最近更新日期: Date of Last Refreshed on: |
2023-05-16 14:06:18 |
|
注册时间: Date of Registration: |
2023-02-22 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
主动脉疾病多模态数据库的建立及多场景临床应用研究临床研究方案 |
|
Public title: |
Establishment of multimodal database of aortic disease and clinical research scheme of multi scene clinical application |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
主动脉疾病多模态数据库的建立及多场景临床应用研究临床研究方案 |
|
Scientific title: |
Establishment of multimodal database of aortic disease and clinical research scheme of multi scene clinical application |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
热亚古丽·柯尤木 |
研究负责人: |
刘昭 |
|
Applicant: |
Reyaguli Keyoumu |
Study leader: |
Zhao Liu |
|
申请注册联系人电话: Applicant telephone: |
+86 155 6919 0727 |
研究负责人电话:
Study leader's |
+86 138 1387 6359 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
reyaggul@163.com |
研究负责人电子邮件: Study leader's E-mail: |
liuzhao83@gmail.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
江苏省南京市中山路321号 |
研究负责人通讯地址: |
江苏省南京市中山路321号 |
|
Applicant address: |
321 Zhongshan Road, Nanjing, Jiangsu |
Study leader's address: |
321 Zhongshan Road, Nanjing, Jiangsu |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
南京鼓楼医院 |
||
|
Applicant's institution: |
Department of Vascular Surgery, Nanjing Drum Tower Hospital |
||
|
研究负责人所在单位: |
南京鼓楼医院 |
||
|
Affiliation of the Leader: |
Department of Vascular Surgery, Nanjing Drum Tower Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2022-678-02 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
南京大学医学院附属鼓楼医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Gulou Hospital Affiliated to Nanjing University Medical School |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-01-12 00:00:00 | ||
|
伦理委员会联系人: |
姜梅玲 |
||
|
Contact Name of the ethic committee: |
Jiang Meiling |
||
|
伦理委员会联系地址: |
南京市中山路321号 |
||
|
Contact Address of the ethic committee: |
321 Zhongshan Road, Nanjing, Jiangsu |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 25 68182923 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
江苏省南京市鼓楼医院血管外科 |
||||||||||||||||||||||
|
Primary sponsor: |
Department of Vascular Surgery, Nanjing Drum Tower Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
江苏省南京市中山路321号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
321 Zhongshan Road, Nanjing, Jiangsu |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
self-financing |
||||||||||||||||||||||
|
研究疾病: |
主动脉疾病 |
||||||||||||||||||||||
|
Target disease: |
Aortic disease |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||
|
研究目的: |
结构化数据、半结构化数据和非结构化数据往往以不同的格式和模型存储,而多模态数据库系统尝试用单一的数据库平台来管理这些数据,将病人的所有数据整合为一个数据库。将所有患者的影像学信息纳入多模态数据库,能大大提高对影像数据特征挖掘和分析的能力,能更好地辅助制定临床治疗方案。 |
||||||||||||||||||||||
|
Objectives of Study: |
Structured data, semi-structured data, and unstructured data are often stored in different formats and models, while multimodal database systems attempt to manage these data with a single database platform, integrating all patient data into one database. Incorporating the imaging information of all patients into the multimodal database can greatly improve the ability to mine and analyze the characteristics of imaging data, and can better assist in formulating clinical treatment plans. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
合并感染性疾病;合并遗传性疾病(如马凡综合征);之前接受过主动脉腔内修复术(TEVAR);以及其他原因无法手术者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Combined with infectious diseases; Combined with hereditary diseases (such as Marfan syndrome); Endoaortic repair (TEVAR) received before; And unable to operate for other reasons. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-11-01 00:00:00至 To 2025-12-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-03-01 00:00:00 至 To 2025-06-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
梅斯医学临床研究平台https://cloud2.medsci.cn/ |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
https://cloud2.medsci.cn/ |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
CRF;梅斯医学 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF;Medsci |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |